What is the purpose of Bortezomib Injection 1mg?
Bortezomib Injection 1mg is a medication that is utilized to treat various myeloma (a sort of malignant growth of the bone marrow). Bortezomib is additionally used to treat mantle cell lymphoma patients (a quickly developing disease that starts in the cells of the invulnerable framework). Bortezomib has a place with the antineoplastic specialist class of medications.
Is Bortezomib Injection 1mga type of chemotherapy?
VELCADE (Bortezomib Injection 1mg) is a form of targeted treatment chemotherapy. VELCADE belongs to the proteasome inhibitors class of drugs. The FDA has given it approval to treat multiple myeloma and mantle cell lymphoma.
Bortezomib is used to treat multiple myeloma?
Velcade inhibits enzyme complexes known as proteasomes. Proteasomes, which break down damaged and undesired proteins into smaller components, are found in both normal and malignant cells.
Is bortezomib associated with hair loss?
Hair thinning. Hair loss isn’t a direct side effect of Velcade, but it could be caused by other medications used alongside it.Individuals utilizing Velcade in addition to the cytotoxic drug cyclophosphamide, for instance, may encounter balding.
What are the bortezomib side effects?
For patients using bortezomib, the following adverse effects are
- prevalent (occurring in more than 30% of cases):
- Generalized weakness, fatigue
- Peripheral neuropathy is characterized by a loss of sensation as well as
- paresthesia (numbness and tingling in the hands and feet).
- Vomiting and nausea.
- Appetite problems.
How long can bortezomib be taken?
Assuming you’ve proactively gotten myeloma treatment, you can have bortezomib all alone. Bortezomib is regularly required two times per week for quite a long time. From that point forward, you get a ten-day rest. A treatment cycle is a three-week time of treatment.
When should you stop taking bortezomib?
Seizures, high blood pressure, headaches, fatigue, disorientation, blindness, or other vision difficulties are all symptoms of PRES. In situations of PRES, VELCADE treatment should be discontinued. It is unknown whether it is safe to restart VELCADE medication in individuals who have previously had this problem.